Profectus BioSciences, Inc. to Present New Data at 12th Annual Conference on Vaccine Research

24 Apr 2009

·www.biospace.com

Vaccine

BALTIMORE--(BUSINESS WIRE)--Profectus BioSciences, Inc. (Profectus), a clinical stage biopharmaceutical company focused on the development of novel vaccine candidates for chronic viral infections, announced today that the company will present new preclinical data at the 12th Annual Conference on Vaccine Research. The conference is taking place in Baltimore, Maryland from April 27-29, 2009. For more information about the conference, please visit

Organizations

Profectus BioSciences, Inc.

Indications

Virus Diseases

Targets

Drugs

Hot reports

Global Drug R&D Express (Apr 2024)

PatSnap Synapse

Global Drug R&D Express (Mar 2024)

PatSnap Synapse

Global Drug R&D Express (Feb 2024)

PatSnap Synapse

Get started for free today!

Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.

Start your data trial now!

Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.